Locked nucleic acid inhibits miR-92a-3p in human colorectal cancer, induces apoptosis and inhibits cell proliferation
Authors:
- 20 May 2016
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 23 (7) , 199-205
Abstract
Cancer Gene Therapy is the essential gene therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene therapy for cancer.Keywords
This publication has 46 references indexed in Scilit:
- microRNA-20a in human faeces as a non-invasive biomarker for colorectal cancerOncotarget, 2015
- Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathwayOncotarget, 2015
- MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7Oncology Reports, 2015
- Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencingMolecular Cancer, 2015
- Five miRNAs Considered as Molecular Targets for Predicting Esophageal CancerMedical Science Monitor, 2015
- The small-molecule compound BM-1197 inhibits the antiapoptotic regulators Bcl-2/Bcl-xL and triggers apoptotic cell death in human colorectal cancer cellsTumor Biology, 2014
- miR-92a family and their target genes in tumorigenesis and metastasisExperimental Cell Research, 2014
- Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancerBMC Cancer, 2012
- MicroRNAs in Vascular and Metabolic DiseaseCirculation Research, 2012
- MicroRNA-17∼92a upregulation by estrogen leads to Bim targeting and inhibition of osteoblasts apoptosisJournal of Cell Science, 2012